Nytol helps UK beat its sleep struggles
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Perrigo is aiming to address the fears people have around sleep aids with a series of “empathetic” television commercials for its Nytol brand in the UK.
You may also be interested in...
Perrigo Helping Pharmacists Get Over Misconceptions About Sleep Aids With UK Nytol Campaign
Perrigo has launched a UK pharmacy-facing trade campaign for Nytol to help pharmacists and pharmacy-staff get over their misconceptions about sleep aids and have better conversations with consumers about their sleep problems.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.